SecBot SecBot
SECBOTREPLAY Home › Report › PCVX

PCVX · CEO Grant Pickering filed a Form 144 notice of intent to sell 24,237…

Vaxcyte, Inc. · 144 filed Jun 26, 2026 at 16:05 ET

At the news

NEUTRALIMPACT 3/10

144 filed Jun 26, 2026 at 16:05 ET

CEO Grant Pickering filed a Form 144 notice of intent to sell 24,237 shares of Vaxcyte (PCVX) with an approximate market value of $1.30M, alongside 2,000 additional shares from family trusts. The filing signals insider selling intent but is a routine diversification move by the CEO, not a distress signal, given the company's $8.1B market cap and strong institutional backing.

  • CEO Grant Pickering filed Form 144 to sell 24,237 shares of Vaxcyte common stock, valued at approximately $1.30M based on the filing date.
  • An additional 2,000 shares are being sold via family trusts (Claire Pickering 2020 Delaware Trust and Benjamin Pickering 2020 Delaware Trust), each valued at ~$52,500.
  • The shares to be sold were acquired through RSU vesting (2023-2025), founder shares (2013), and prior RSU vesting (2024).
  • The filing is an advance notice of intent to sell, not a completed transaction, the sale may not occur.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access